REGIONAL ACTIVITIES 2026 | CME/MOC Accredited

About the Program
Research To Practice (RTP) is pleased to offer hospitals and cancer centers nationwide the opportunity to participate in an interactive, live continuing education program. Each session in this regional series features renowned faculty delivering a didactic presentation, sharing steering committee treatment recommendations and engaging attendees through interactive Q&A discussion.

What’s included:

If you are interested in hosting a session at your institution, please email our Meetings Department at Meetings@ResearchToPractice.com or call (800) 233-6153.

Upcoming Sessions:

Integrating Recent Advances into the Management of Gastroesophageal Cancers

Integrating Recent Advances into the Management of HER2-Positive Breast Cancer

Integrating Recent Advances into the Management of Metastatic Hormone-Sensitive Prostate Cancer

Integrating Recent Advances into the Management of Relapsed/Refractory Multiple Myeloma: Bispecifics, ADCs and CELMoDs

Optimizing the Use of Novel Therapies for Patients with Diffuse Large B-Cell Lymphoma

Optimizing Therapy for Patients with Hormone Receptor-Positive Localized Breast Cancer

Second Opinion: Investigators Provide Perspectives on the Optimal Management of HER2-Positive Gastrointestinal Cancers 

Second Opinion: Investigators Provide Perspectives on the Potential Role of RAS Inhibition in the Management of Pancreatic Cancer

Where We Are, Where We’re Headed: Current and Future Management of Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Antibody Therapy


Additional topics will be announced throughout 2026.